Koumaki Dimitra, Papadakis Marios, Kouloumvakou Stamatoula, Krasagakis Konstantinos
Department of Dermatology, University Hospital of Heraklion, Heraklion 71110, Greece.
Department of Surgery II, University of Witten-Herdecke, Wuppertal 42283, Germany.
World J Clin Oncol. 2022 Jul 24;13(7):587-598. doi: 10.5306/wjco.v13.i7.587.
Patients with atypical mole syndrome (AMS) have a 3- to 20-fold higher risk of developing malignant melanoma (MM) than individuals without. The most modifiable risk factor for developing MM is the ongoing ultraviolet exposure.
To assess awareness, knowledge, and attitudes towards sun protection among patients with MM and AMS.
From January 2020 till December 2021, a written survey was administered to patients with MM and AMS and a control group who attended a specialist mole clinic at the Dermatology Department of the University Hospital of Heraklion in Heraklion, Crete, Greece. Demographic data and photoprotective practices, knowledge, and perceived barriers were collected. Relevant statistical analyses were performed using SPSS IBM 25.
In total, 121 subjects consented and participated in the survey. Their mean age was 43.92 ± 12.55 years. There were 66 (54.4%) females and 55 (45.4%) males. Forty-seven (38.8%) patients had AMS, 26 (21.5%) had a past medical history of MM, and 48 (39.7%) attended the clinic for a full skin checkup for their naevi without having AMS or MM. Although 104 (86%) participants reported using sunscreen with the majority of them (59/121 = 48.8%) wearing sunscreen with a sun protection factor of > 50, only 22 (18.2%) patients did so every day and only 20 (16.5%) all year round. Approximately 74.4% of patients recalled having received advice on how to protect their skin from sunlight, and 73% were interested in receiving education about sun protection. The most mentioned barriers in photoprotection were concerns over adequate vitamin D and lack of time.
Despite mentioning having received adequate education in photoprotection, adherence to photoprotection practices is suboptimal in patients with MM and AMS.
非典型痣综合征(AMS)患者患恶性黑色素瘤(MM)的风险比无该综合征的个体高3至20倍。患MM最可改变的风险因素是持续的紫外线暴露。
评估MM和AMS患者对防晒的认知、知识和态度。
2020年1月至2021年12月,对在希腊克里特岛伊拉克利翁大学医院皮肤科专科痣诊所就诊的MM和AMS患者及一个对照组进行了书面调查。收集了人口统计学数据以及光防护措施、知识和感知到的障碍。使用IBM SPSS 25进行了相关统计分析。
共有121名受试者同意并参与了调查。他们的平均年龄为43.92±12.55岁。有66名(54.4%)女性和55名(45.4%)男性。47名(38.8%)患者患有AMS,26名(21.5%)有MM病史,48名(39.7%)因痣进行全身体检而就诊于该诊所,他们既没有AMS也没有MM。尽管104名(86%)参与者报告使用防晒霜,其中大多数人(59/121 = 48.8%)使用防晒系数>50的防晒霜,但只有22名(18.2%)患者每天都这样做,只有20名(16.5%)患者全年都这样做。大约74.4%的患者回忆起曾收到过如何保护皮肤免受阳光照射的建议,73%的患者有兴趣接受防晒教育。光防护中最常提到的障碍是对充足维生素D的担忧和缺乏时间。
尽管提到接受了足够的光防护教育,但MM和AMS患者对光防护措施的依从性仍不理想。